Skip to content
Medical Health Aged Care

New mobile app helps people track their methamphetamine use and reduce drug-related harms

NDARC/NCCRED/UNSW 2 mins read

Researchers at the National Centre for Clinical Research on Emerging Drugs (NCCRED) have launched the S-Check app to encourage people who use methamphetamine to seek help and treatment earlier.

S-Check is a self-administered smartphone app for people to track their methamphetamine use, monitor the impact of the drug on their health and wellbeing, and get tips and support for any health issues.

Based on the Stimulant Check-Up (S-Check) service model at St Vincent’s Hospital Sydney (SVHS), the app is aimed at engaging people who have not previously accessed traditional modes of treatment to reduce harms and to encourage them to seek treatment before problematic methamphetamine use begins or becomes entrenched.

The team at NCCRED, which is based at SVHS and the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney, said they hoped to address the substantial delays in treatment seeking that is typical among individuals with problematic methamphetamine use.

“The time between problems arising due to methamphetamine use and seeking treatment can be up to 10 years, and existing treatment options for people who use methamphetamine are limited,” said NCCRED Clinical Research Lead, Dr Krista Siefried.

“Apps like S-Check provide an option for people who are curious about their use or looking for resources while they wait for treatment.”

S-Check allows individuals to complete self-assessments to understand the impact of methamphetamine use on their broader health, such as their psychological wellbeing and sexual health.

Information collected in the app can also be shared with an individual’s doctor or other healthcare provider for a more tailored health assessment.

The launch of S-Check follows promising results from a 28-day clinical trial that included 560 Australian adults who reported methamphetamine use at least once a month, half of whom had immediate access to the app.

“In a randomised trial this app supported people in exploring their methamphetamine use and its impacts on their sexual, psychological and physical health,” said Dr Siefried.

“People who had immediate access were more likely to seek out professional help in the following 28 days than those who were randomised to wait.”

The 2023 study showed that compared to the control group, almost twice as many participants with immediate access to S-Check sought professional help by day 28.

Furthermore, among those not seeking help at baseline, each minute spent using the app increased the likelihood of seeking professional help by 8% by the end of the trial.

S-Check can be downloaded for free from the iOS and Android app stores.

-ENDS-


Contact details:

Dr Krista Siefried is available for media interviews.

Media contact: 0401 713 850 | ndarc.media@unsw.edu.au

For reference: When reporting on drugs and alcohol, we encourage consultation of the Mindframe guidelines on Communicating about alcohol and other drugs’ and ‘Communicating about suicide, and the ‘Language Matters guide published by the NSW Users and AIDS Association. 

We also encourage inclusion of the following helpline information in all reporting:

People can access free and confidential advice about alcohol and other drugs by calling the National Alcohol and Other Drug Hotline on 1800 250 015.

More from this category

  • Medical Health Aged Care
  • 17/01/2025
  • 01:40
King Faisal Specialist Hospital & Research Centre

King Faisal Specialist Hospital and Research Centre Performs the World’s First Robotic-Assisted Artificial Heart Pump Implantation

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first robotic-assisted implantation of an artificial heart pump (HeartMate 3) developed by Abbott, a groundbreaking procedure that marks a significant advancement in medical technology and patient care.The surgery was performed on a 35-year-old man who had been hospitalized for 120 days due to advanced heart failure, which had also led to kidney and lung function deterioration. Thanks to this innovative surgical procedure, the patient is now on track to fulfill his dream of returning home to…

  • Medical Health Aged Care
  • 17/01/2025
  • 00:26
Novotech

Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials

Key biomarkers and cutting-edge treatments, such as PARP inhibitors and immunotherapy combinations, drive advancements in TNBC outcomes SYDNEY–BUSINESS WIRE– Novotech, the leading global full-service…

  • Contains:
  • Medical Health Aged Care
  • 16/01/2025
  • 23:55
King Faisal Specialist Hospital & Research Centre

NOTICE TO DISREGARD — King Faisal Specialist Hospital & Research Centre

RIYADH, Saudia Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- We are advised by King Faisal Specialist Hospital & Research Centre that journalists and other readers should disregard the news release, “KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide” issued January 16, 2025, over GlobeNewswire.

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.